Abstract:What's new? The underlying causes of the rising incidence of early‐onset (diagnosed before age 50) colorectal cancer (EOCRC) in the United States remain largely unclear. Here, by investigating the associations of EOCRC with 11 environmental exposures on the population level, we identified excess body weight as the strongest risk factor, and estimated that excess body weight contributed to about 30% of EOCRC incidence during 1992 to 2016. Our findings suggest that prevention of excess body weight may help curb the EOCRC epidemic. Incidence of early‐onset (diagnosed before age 50) colorectal cancer (EOCRC) has increased alarmingly since the 1990s in the United States. This study investigated what environmental exposures may have driven this increase. We obtained EOCRC incidence data from the Surveillance, Epidemiology, and End Results Program, and data for 11 exposures, for example, body mass index (BMI), from long‐term national surveys. We aggregated these data for 30 to 49‐year‐olds during 1992 to 2016 by population subgroups defined by calendar period, age, race and sex, and used negative binomial regression models to identify and estimate associations of EOCRC with multiple exposures. Furthermore, we used counterfactual modeling to quantify contributions of identified risk factors to EOCRC incidence. The top models (with lowest Bayesian Information Criteria) consistently identified excess body weight, represented by overweight and obesity (BMI ≥25) or obesity alone (BMI ≥30), as the strongest risk factor. The best‐performing model estimated increased EOCRC incidence due to overweight and obesity, with an incidence rate ratio (95% confidence interval) of 1.20 (1.17‐1.22) for white men, 1.04 (1.00‐1.08) for black men, 1.17 (1.15‐1.21) for white women and 1.03 (0.97‐1.08) for black women. Increases in overweight and obesity prevalence contributed to an estimated 30% (standard error: 1%) for men and 28% (standard error: 2%) for women of ECORC incidence during 1992 to 2016. These findings suggest excess body weight substantially contributed to and is likely a primary driver of the rising incidence of EOCRC in the United States. Prevention of excess weight gain may help lower colorectal cancer risk early in life.

Early-onset colorectal cancer: initial clues and current views

Unraveling the complexities of early-onset colorectal cancer: a perspective on dietary and microbial influences

Behavioral Risk Factors and Risk of Early-Onset Colorectal Cancer: Review of the Mechanistic and Observational Evidence

Early-onset colorectal cancer: Current insights and future directions

Epidemiology and biology of early onset colorectal cancer

Early-Onset colorectal Cancer: From the laboratory to the clinic

Field synopsis of environmental and genetic risk factors of sporadic early-onset colorectal cancer and advanced adenoma.

Obesity and early-onset colorectal cancer risk: emerging clinical evidence and biological mechanisms

Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer

[Emphasis on awareness of early-onset colorectal cancer]

Risk factors for early-onset colorectal cancer: A Canadian prospective cohort study

Rising incidence of early-onset colorectal cancer — a call to action

Causes and Prevention of Early-Onset Colorectal Cancer

Early onset colorectal cancer, not just the age: Data from a large health organization

Environmental drivers of the rising incidence of early‐onset colorectal cancer in the United States

Risk factors for early-onset colorectal cancer: A large-scale Chinese cohort study

Oncotherapeutic Strategies in Early Onset Colorectal Cancer

The Impact of the Gut Microbiome, Environment, and Diet in Early-Onset Colorectal Cancer Development

Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer

Risk factors, histopathological landscape, biomarkers, treatment patterns and survival of early‐onset colorectal cancer: A narrative review

Is early-onset colorectal cancer an evolving pandemic? Real-world data from a tertiary cancer center